BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35698197)

  • 1. An update on choroidal abnormalities and retinal microvascular changes in neurofibromatosis type 1.
    Mallone F; Lucchino L; Giustini S; Lambiase A; Moramarco A
    Orphanet J Rare Dis; 2022 Jun; 17(1):223. PubMed ID: 35698197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.
    Moramarco A; Mallone F; Sacchetti M; Lucchino L; Miraglia E; Roberti V; Lambiase A; Giustini S
    Orphanet J Rare Dis; 2021 Mar; 16(1):147. PubMed ID: 33757576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1.
    Mallone F; Alisi L; Lucchino L; Di Martino V; Nebbioso M; Armentano M; Lambiase A; Moramarco A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1).
    Stemmer-Rachamimov AO; Kozanno L; Plotkin SR; Jordan JT; Rd Rizzo JF
    Acta Neuropathol; 2024 Apr; 147(1):71. PubMed ID: 38607446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectropion Uveae in neurofibromatosis type 1: a new manifestation.
    Iacovino C; Miraglia E; Moramarco A; Corbo G; Lambiase A; Giustini S
    Clin Ter; 2021 May; 172(3):206-208. PubMed ID: 33956037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mandibular neurofibroma with osseous deformities in a 3-year-old child with neurofibromatosis type 1: A case report presentation and diagnosis.
    Aloyouny AY; Albagieh HN; Alweteid AS; Alsheddi MA
    Niger J Clin Pract; 2021 Nov; 24(11):1755-1757. PubMed ID: 34782519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal microvascular abnormalities in neurofibromatosis type 1.
    Moramarco A; Miraglia E; Mallone F; Roberti V; Iacovino C; Bruscolini A; Giustolisi R; Giustini S
    Br J Ophthalmol; 2019 Nov; 103(11):1590-1594. PubMed ID: 30705042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I neurofibromatosis: a geno-oculo-dermatologic update.
    Schnur RE
    Curr Opin Ophthalmol; 2012 Sep; 23(5):364-72. PubMed ID: 22871881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exuberant manifestation of neurofibromatosis type 1 affecting 3 generations: delayed diagnosis and the importance of the multidisciplinary approach.
    Tolentino ES; Souza Pinto GN; Maciel L; Soares CT; Lara VS; Moreschi ARC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Sep; 128(3):e108-e112. PubMed ID: 31101459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
    Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
    Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
    Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
    Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lisch nodule in neurofibromatosis type 1].
    Abaloun Y; Ajhoun Y
    Pan Afr Med J; 2017; 27():218. PubMed ID: 28979620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
    Solares I; Vinal D; Morales-Conejo M
    Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
    Chilibeck CM; Shah S; Russell HC; Vincent AL
    Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurofibromatosis type 1.
    Boyd KP; Korf BR; Theos A
    J Am Acad Dermatol; 2009 Jul; 61(1):1-14; quiz 15-6. PubMed ID: 19539839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.